Blincyto Approval Expanded for Specific Leukemia

THURSDAY, March 29, 2018 -- The U.S. Food and Drug Administration says it has expanded approval for Blincyto (blinatumomab) to include adults and children with B-cell precursor acute lymphoblastic leukemia who are in remission but who still have...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news